Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)

Market Cap	2.50B
Revenue (ttm)	755.34M
Net Income (ttm)	7.50M
Shares Out	235.30M
EPS (ttm)	0.03
PE Ratio	332.69
Forward PE	n/a
Dividend	0.12 (1.14%)
Ex-Dividend Date	n/a

Volume	3,789,096
Average Volume	4,394,060
Open	10.30
Previous Close	10.49
Day's Range	10.30 - 10.61
52-Week Range	7.41 - 15.19
Beta	0.08
RSI	63.31
Earnings Date	Mar 31, 2026

About SHE:002873

Guiyang Xintian Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of new Chinese patent medicines in China. The company offers products in various dosage forms, including hard capsules, mixtures, granules, gels, tablets, syrups, wine preparation, dews preparations, and two Chinese medicine preparation production lines. Its products are used for the treatment of gynecological and urinary diseases, as well as oral, breast and thyroid, anti-cold, heat-clearing, blood-tonifying, cardiovascular disease, and antitu...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 1,682
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002873

Financial Performance

In 2024, SHE:002873's revenue was 857.55 million, a decrease of -10.11% compared to the previous year's 953.98 million. Earnings were 52.32 million, a decrease of -35.30%.